Literature DB >> 27270519

Colorectal Surgery Outcomes in Chronic Dialysis Patients: An American College of Surgeons National Surgical Quality Improvement Program Study.

Anne-Marie E Sirany1, Christopher J Chow, Hiroko Kunitake, Robert D Madoff, David A Rothenberger, Mary R Kwaan.   

Abstract

BACKGROUND: More than 450,000 US patients with end-stage renal disease currently dialyze. The risk of morbidity and mortality for these patients after colorectal surgery has been incompletely described.
OBJECTIVE: We analyzed the 30-day morbidity and mortality rates of chronic dialysis patients who underwent colorectal surgery.
DESIGN: This was a retrospective analysis. SETTINGS: Hospitals that participate in the American College of Surgeons National Surgical Quality Improvement Program were included. PATIENTS: The study included adult patients who underwent emergency or elective colon or rectal resection between 2009 and 2014. MAIN OUTCOME MEASURES: Baseline characteristics were compared by dialysis status. The impact of chronic dialysis on 30-day mortality and serious postoperative morbidity was examined using multivariate logistic regression.
RESULTS: We identified 128,757 patients who underwent colorectal surgery in the American College of Surgeons National Surgical Quality Improvement Program database. Chronic dialysis patients accounted for 1% (n = 1285) and were more likely to be older (65.4 vs 63.2 years; p < 0.0001), black (27.2% vs 8.7%; p < 0.0001), preoperatively septic (22.1% vs 7.1%; p < 0.0001), require emergency surgery (52.0% vs 14.7%; p < 0.0001), have ischemic bowel (15.7% vs 1.6%; p < 0.0001), or have perforation/peritonitis (15.5% vs 4.2%; p < 0.0001). Chronic dialysis patients were also less likely to have a laparoscopic procedure (17.3% vs 45.0%; p < 0.0001). Chronic dialysis patients had higher unadjusted mortality (22.4% vs 3.3%; p < 0.0001), serious postoperative morbidity (47.9% vs 18.8%; p < 0.0001), and median length of stay (9 vs 6 days; p < 0.0001). In emergent cases (n = 19,375), multivariate logistic regression models demonstrated a higher risk of mortality for dialysis patients (OR = 1.73 (95% CI, 1.38-2.16)) but not for serious morbidity. Models for elective surgery demonstrated a similar effect on mortality (OR = 2.47 (95% CI, 1.75-3.50)) but also demonstrated a higher risk of serious morbidity (OR = 1.28 (95% CI, 1.04-1.56)). LIMITATIONS: The postoperative 30-day window may underestimate the true incidence of serious morbidity and mortality.
CONCLUSIONS: Chronic dialysis patients undergoing elective or emergent colorectal procedures have a higher risk-adjusted mortality.

Entities:  

Mesh:

Year:  2016        PMID: 27270519     DOI: 10.1097/DCR.0000000000000609

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  3 in total

1.  Increased 30-Day Mortality Risk in Patients With Diabetes Mellitus After Colon Cancer Surgery: A Mediation Analysis.

Authors:  Mario Schootman; Donna B Jeffe; Kendra L Ratnapradipa; Jan M Eberth; Nicholas O Davidson
Journal:  Dis Colon Rectum       Date:  2020-03       Impact factor: 4.585

2.  Comparisons of postoperative outcomes after breast cancer surgery in patients with and without renal replacement therapy: a matched-pair cohort study using a Japanese nationwide inpatient database.

Authors:  Takaaki Konishi; Michimasa Fujiogi; Nobuaki Michihata; Kojiro Morita; Hiroki Matsui; Kiyohide Fushimi; Masahiko Tanabe; Yasuyuki Seto; Hideo Yasunaga
Journal:  Breast Cancer       Date:  2021-04-10       Impact factor: 4.239

3.  Association of pre-operative chronic kidney disease and acute kidney injury with in-hospital outcomes of emergency colorectal surgery: a cohort study.

Authors:  Katsunori Miyake; Masao Iwagami; Takayasu Ohtake; Hidekazu Moriya; Nao Kume; Takaaki Murata; Tomoki Nishida; Yasuhiro Mochida; Naoko Isogai; Kunihiro Ishioka; Rai Shimoyama; Sumi Hidaka; Hiroyuki Kashiwagi; Jun Kawachi; Hidemitsu Ogino; Shuzo Kobayashi
Journal:  World J Emerg Surg       Date:  2020-03-26       Impact factor: 5.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.